Galectin-3 as a potential marker of myocardial hypertrophy in essential hypertension in individuals with polymorphic AT1R genotypes. Biomedical Research and Therapy, [S. l.], v. 5, n. 8, p. 2633–2644, 2018. DOI: 10.15419/bmrat.v5i8.471. Disponível em: https://preservation.bmrat.org/index.php/BMRAT/article/view/471.. Acesso em: 3 mar. 2025.